Pluristem

@Pluristem

A bio-therapeutics company developing a pipeline of products derived from human placenta - a non-controversial adult stem cell source.

Haifa, Israel
دسمبر 2010 کو شامل ہوئے

@Pluristem بلاک ہے

کیا آپ واقعی یہ ٹویٹس دیکھنا چاہتے ہیں؟ ٹویٹس دیکھنے سے @Pluristem ان بلاک نہیں ہوں گے۔

  1. Retweeted

    Now at : Adaptive pathways & early market access roundtable, feat

  2. Pluristem CEO Zami Aberman welcomes Japanese Ambassador, Koji Tomita to Haifa labs

  3. If you missed us at the recent ARM Investor Day conference, here is our presentation:

  4. Retweeted

    . Therapeutics CEO, Zami Aberman explains to how will shape the industry

  5. Pluristem followed ، ، اور 6 دیگر
    • @ajcla

      The Los Angeles office of - Enhancing the wellbeing of the Jewish people & Israel, advancing human rights & democratic values around the world.

    • @AndyKempFSG

      Business Development Manager

  6. Retweeted

    . VP provides updates on PLX-PAD critical limb ischemia treatment in EU & Japan, & more

  7. Retweeted

    Maxim's Jason Kolbert discusses ARC and radiation poisoning countermeasures

  8. Retweeted

    NEW: CEO on placental stem therapy ""off the shelf"" promise

  9. Reuters TV covers our technology against radiation sickness:

  10. SNNLive caught up with Karine Kleinhaus from at Source Capital Disruptive Growth & Healthcare Conference NYC

  11. Pluristem's Radiation Antidote Bests Blockbuster Drug Neupogen:

  12. Retweeted

    Therapeutics Specializes in Placental Derived PLX Cells via

  13. Our chairman and CEO explains to Mike Ward from Informa Pharma Insights how cell therapy will shape the industry.

  14. Q&A Interview with Dr. Racheli Ofir, VP of Research & Intellectual Property at Pluristem Therapeutics:

لوڈنگ میں وقت لگ رہا ہے.

ٹوئٹر گنجائش سے زیادہ بوجھ یا ایک وقتی مشکل سے دوچار ہے۔ دوبارہ کوشش کریں یا مزید معلومات کے لیے ٹوئٹر اسٹیٹسپر جائیں۔

    You may also like

    ·